On March 10, 2026, a significant volume of Medline Inc. (MDLN) shares were sold by numerous insiders. A total of 29 insiders, primarily entities identified as 10% owners, divested approximately $31.04 billion worth of stock. Each of these sales involved 26,105,840 shares transacted at a price of $41.00 per share, with individual sale values reaching approximately $1.07 billion for each entity.
The selling entities include various limited partnerships and limited liability companies affiliated with TC Group, Carlyle Group, and CPEP. These transactions represent a substantial liquidation of holdings by major stakeholders within Medline Inc.
While insider selling can be attributed to a variety of reasons such as portfolio diversification, tax obligations, or personal financial needs, the coordinated nature and sheer volume of these sales by multiple 10% owners may attract investor attention.